title: Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study.
abstract: In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution.
authors.affiliation: Department of Urology, APHP Bicêtre University Hospital, Le Kremlin-Bicêtre, France.
authors.forename: P
authors.initials: P
authors.lastname: Eschwège
authors.forename: S
authors.initials: S
authors.lastname: Moutereau
authors.forename: S
authors.initials: S
authors.lastname: Droupy
authors.forename: R
authors.initials: R
authors.lastname: Douard
authors.forename: J-L
authors.initials: JL
authors.lastname: Gala
authors.forename: G
authors.initials: G
authors.lastname: Benoit
authors.forename: M
authors.initials: M
authors.lastname: Conti
authors.forename: P
authors.initials: P
authors.lastname: Manivet
authors.forename: S
authors.initials: S
authors.lastname: Loric
mesh_terms: D000368:Aged; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood; D009367:Neoplasm Staging; D009360:Neoplastic Cells, Circulating; D011379:Prognosis; D011446:Prospective Studies; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology* / Q000601:surgery